Yasuharu Tamai

EPS Holdings, Inc. engages in the drug development business. It operates through the following segments: Contract Research Organization (CRO), Site Management Organization (SMO), Contract Sales Organization (CSO), Global Research, Ekishin, and Others. The CRO segment offers clinical trials, data management, and statistical analysis. The SMO segment enters into contracts with medical institutions to conduct clinical trials. The CSO segment provides drug information and awareness for medical and pharmaceutical industries. The Global Research segment provides consignment services through its subsidiary for multilateral clinical trials in Asia-Pacific. The Ekishin segment focuses on medical equipment, pharmaceutical and investment related businesses through its Japan and China based subsidiaries. The Others segment provides various services related to management of clinical research from business processing outsource business related to medicine and medical care. The company was founded on May 30, 1991 and is headquartered in Tokyo, Japan.

Medical Line Co., Ltd. provides medical call center services. Its services include telephone support, multi-function contact Web, electronic mail response to the query, and feedback information management, and customer satisfaction. The company was founded in September 1, 2006 and is headquartered in Tokyo, Japan.

Part of EPS Holdings, Inc., EPS Corp. (New) is a pharmaceutical and medical equipment development business contracted organization. The company is based in Tokyo, Japan. The Japanese company's website includes information on their RBM service and contract results. EPS Corp. (New was founded in 2014 and provides CRO services for the development of pharmaceuticals and medical equipment.